477 related articles for article (PubMed ID: 16483933)
1. Hypoxia-induced energy stress regulates mRNA translation and cell growth.
Liu L; Cash TP; Jones RG; Keith B; Thompson CB; Simon MC
Mol Cell; 2006 Feb; 21(4):521-31. PubMed ID: 16483933
[TBL] [Abstract][Full Text] [Related]
2. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.
Smith EM; Finn SG; Tee AR; Browne GJ; Proud CG
J Biol Chem; 2005 May; 280(19):18717-27. PubMed ID: 15772076
[TBL] [Abstract][Full Text] [Related]
3. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.
Tee AR; Manning BD; Roux PP; Cantley LC; Blenis J
Curr Biol; 2003 Aug; 13(15):1259-68. PubMed ID: 12906785
[TBL] [Abstract][Full Text] [Related]
4. Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation.
Alam H; Maizels ET; Park Y; Ghaey S; Feiger ZJ; Chandel NS; Hunzicker-Dunn M
J Biol Chem; 2004 May; 279(19):19431-40. PubMed ID: 14982927
[TBL] [Abstract][Full Text] [Related]
5. cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity.
Xie J; Ponuwei GA; Moore CE; Willars GB; Tee AR; Herbert TP
Cell Signal; 2011 Dec; 23(12):1927-35. PubMed ID: 21763421
[TBL] [Abstract][Full Text] [Related]
6. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets.
Arsham AM; Howell JJ; Simon MC
J Biol Chem; 2003 Aug; 278(32):29655-60. PubMed ID: 12777372
[TBL] [Abstract][Full Text] [Related]
7. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR
Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235
[TBL] [Abstract][Full Text] [Related]
8. Oxygen sufficiency controls TOP mRNA translation via the TSC-Rheb-mTOR pathway in a 4E-BP-independent manner.
Miloslavski R; Cohen E; Avraham A; Iluz Y; Hayouka Z; Kasir J; Mudhasani R; Jones SN; Cybulski N; Rüegg MA; Larsson O; Gandin V; Rajakumar A; Topisirovic I; Meyuhas O
J Mol Cell Biol; 2014 Jun; 6(3):255-66. PubMed ID: 24627160
[TBL] [Abstract][Full Text] [Related]
9. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.
Inoki K; Li Y; Xu T; Guan KL
Genes Dev; 2003 Aug; 17(15):1829-34. PubMed ID: 12869586
[TBL] [Abstract][Full Text] [Related]
10. Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis.
Horman S; Browne G; Krause U; Patel J; Vertommen D; Bertrand L; Lavoinne A; Hue L; Proud C; Rider M
Curr Biol; 2002 Aug; 12(16):1419-23. PubMed ID: 12194824
[TBL] [Abstract][Full Text] [Related]
11. TSC2 mediates cellular energy response to control cell growth and survival.
Inoki K; Zhu T; Guan KL
Cell; 2003 Nov; 115(5):577-90. PubMed ID: 14651849
[TBL] [Abstract][Full Text] [Related]
12. PDK4 protein promotes tumorigenesis through activation of cAMP-response element-binding protein (CREB)-Ras homolog enriched in brain (RHEB)-mTORC1 signaling cascade.
Liu Z; Chen X; Wang Y; Peng H; Wang Y; Jing Y; Zhang H
J Biol Chem; 2014 Oct; 289(43):29739-49. PubMed ID: 25164809
[TBL] [Abstract][Full Text] [Related]
13. AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions.
Thomson DM; Fick CA; Gordon SE
J Appl Physiol (1985); 2008 Mar; 104(3):625-32. PubMed ID: 18187610
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells.
Connolly E; Braunstein S; Formenti S; Schneider RJ
Mol Cell Biol; 2006 May; 26(10):3955-65. PubMed ID: 16648488
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif.
Land SC; Tee AR
J Biol Chem; 2007 Jul; 282(28):20534-43. PubMed ID: 17502379
[TBL] [Abstract][Full Text] [Related]
16. Rheb binds and regulates the mTOR kinase.
Long X; Lin Y; Ortiz-Vega S; Yonezawa K; Avruch J
Curr Biol; 2005 Apr; 15(8):702-13. PubMed ID: 15854902
[TBL] [Abstract][Full Text] [Related]
17. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells.
Misra UK; Pizzo SV
PLoS One; 2012; 7(12):e51735. PubMed ID: 23272152
[TBL] [Abstract][Full Text] [Related]
18. c-myc Repression of TSC2 contributes to control of translation initiation and Myc-induced transformation.
Ravitz MJ; Chen L; Lynch M; Schmidt EV
Cancer Res; 2007 Dec; 67(23):11209-17. PubMed ID: 18056446
[TBL] [Abstract][Full Text] [Related]
19. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2.
Garami A; Zwartkruis FJ; Nobukuni T; Joaquin M; Roccio M; Stocker H; Kozma SC; Hafen E; Bos JL; Thomas G
Mol Cell; 2003 Jun; 11(6):1457-66. PubMed ID: 12820960
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.
Corradetti MN; Inoki K; Bardeesy N; DePinho RA; Guan KL
Genes Dev; 2004 Jul; 18(13):1533-8. PubMed ID: 15231735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]